BDBM238292 US10052306, 284::tert-butyl (5-(2-(5-benzyl- 5- hydroxyhexahydrocyclo- penta[c]pyrrol-2(1H)- yl)acetyl)pyridin-2- yl)carbamate

SMILES CC(C)(C)OC(=O)Nc1ccc(cn1)C(=O)CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1

InChI Key InChIKey=UGTLUJMGNKSDMI-VSVJTWGKSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 238292   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM238292(US10052306, 284 | tert-butyl (5-(2-(5-benzyl- 5- h...)
Affinity DataIC50:  1.00E+4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent